SlideShare une entreprise Scribd logo
1  sur  32
PATHOGENESIS  BOTH  :  insulin deficiency   +   elevation of counterregulatory hormones  (glucagon, catecholamines, cortisol, growth hormone) ↓ Increase hepatic & renal glucose production Impaired glucose utilization in peripheral tissues ↓ Hyperglycemia & increase plasma osmolality
PATHOGENESIS DKA :  release of free fatty acids (lipolysis) ↓ Hepatic fatty acid oxidation to ketone bodies (β-hydroxybutyrate & acetoacetate) ↓ Ketonemia & metabolic acidosis
PATHOGENESIS HHS :  Plasma insulin  – inadequate for glucose utilization  ‒ adequate to prevent lipolysis & ketogenesis DKA & HHS :    ― magnitude of dehydration   ― degree of ketosis (& acidosis)
PRECIPITATING  FACTORS ● Infection ● Cerebrovascular accident ● Alcohol abuse ● Pancreatitis ● Myocardial infarction ● Trauma ● Drugs e.g. steroids, thiazides, sympathomimetic   agents (dobutamine & terbutaline) ● Stop/inadequate insulin in DM type I ● Elderly with new-onset DM
DIAGNOSIS History & physical examination : Process :       - HHS : over several days to weeks      - DKA : much shorter (typically < 24 hr) 2) Classical clinical picture of both :      - polyuria                 - polydipsia      - polyphagia            - weight loss      - vomitting               - abdominal pain (DKA)      - dehydration           - weakness      - clouding of sensoria    - coma
DIAGNOSIS 3) Physical finding :     - poor skin tugor     - Kussmaul respiration (DKA)     - tachycardia                - hypotension     - alteration of conscious (lethargy  coma :HHS)     - emesis (coffee-ground)     - hypothermia (peripheral vasodilatation)     - abdominal pain        (DKA : Rx dehydration & metabolic  acidosis)
LABORATORY  FINDINGS : 1)Initial lab :      - BS, BUN, Cr, serum ketone     - electrolyte (with calculated anion gap)  •pseudohypoNa : osmotic gradient from hypergly.         • true hypoNa  from severe hyperTG        • hyperK  from insulin deficiency,hypotonicity&  acidemia(cell shift)      - osmolality : ≥ 320 mOsm/kg  stupor/coma         = 2 [measured Na (mEq/L) + BS (mg/dl)/18)      - CBC with diff count (leukocytosisὰ serum ketone)      - U/A, urine ketone
LABORATORY  FINDINGS : 1)Initial lab:      - EKG       - HbA1C : acute or chronic poor control 2) Suspected infection :       - bacterial cultures of urine,blood & throat ,etc       - CxR       - abdominal pain : pancreatitis  serum lipase         (DKA : increase serum amylase & liver enz )
DIFFERENTIAL  DIAGNOSIS : Ketoacidosis:         - Starvation ketosis        - Alcoholic ketoacidosis          mildly elevation BS (rarely > 250 mg/dl)          serum HCO3 not < 18 mEQ/L 2) High-anion gap metabolic acidosis :      - Lactic acidosis (Ix : serum lactate)      - drugs :          • salicylate (Ix : serum salicylate),          • methanol (Ix : serum methanol)         • ethylene glycol            (Ix : U/A-calcium oxalate &hippurate crystal),
DIFFERENTIAL  DIAGNOSIS :  2) High-anion gap metabolic  acidosis :      - paraldehyde        (strong odor breathing-osmolar gap-          anion gap acidosis)      - Chronic renal failure (hyperchloremic acidosis)
TREATMENT : Correction of dehydration, hyeprglycemia & E’lyte imbalance 2) Correct precipitating factor 3) Guideline for management
Fluid therapy : Adult patients :      - initial fluid Rx in no cardiac compromise :          0.9%NaCl  ≥ 15-20 ml/kg/hr  in 1st hour         ( ~ 1-1.5 L )      - subsequent  choice for fluid depend on         hydration, serum E’lyte & urine output          • if N/↑serum Na  0.45% NaCl 4 – 14 ml/kg          • if ↓ serum Na  0.9% NaCl      - monitor BP; fluid input/output ; clinical exam ; sermoosmolality not > 3 mOsm/kg/H2O/hr      - fluid replacement correct deficit in 24 hr
FLUID  THERAPY : 2) Pediatric patients (< 20 yrs) :      - 1st hr : 0.9%NaCl  10-20 ml/hr         ( not > 50 ml/kg in first 4 hr of therapy )       - Continued fluid therapy = fluid deficit in 48 hr or        1.5 times of 24 hr maintenance  or 5 ml/kg/hr             • 0.45-0.9% NaCl rate           • ↓ osmolality not > 3 mOsm/kg/hr      - serum glucose = 250 mg/dl             change 5%DN/2 or 5%D/N/3 with potassium
INSULIN  THERAPY : Not mild DKA :      Rx of choice = regular insulin continuous IV infusion     Exclude hypoK (< 3.3 mEq/l)      Start regular insulin 0.15 units/kg iv bolus       (iv bolus nit recommend in pediatric)     Cont. infusion 0.1 units/kg/hr (5-7 units/hr in adult)      Aim decrease BS 50-75 mg/dl/hr     If  in 1st hr BS not decrease > 50 mg/dl            • check hydration           • double dose insulin infusion every hr
INSULIN  THERAPY : when BS = 250 mg/dl in DKA  or                  = 300 mg/dl in HHS      • ↓ insulin infusion rate = 0.05 - 0.1 unit/kg/hr         (3-6 units/hr)      • 5-10% Dextrose Keep until   acidosis in DKA                     mental status  hyperosmolarity  in HHS        resolve
INSULIN  THERAPY : Ketonemia    • longer ot clear than hyperglycemia    • monitor by measure serum β-OHB      during Rx β-OHB  acetoacetic ȃ  worse ketosis      then not use urine / serum ketone level for Rx During Rx : monitor serum E’lyte , BS, BUN, Cr,  osmolality & venous pH (for DKA) q 2-4 hr                    ( venous pH < arterial pH = 0.03 units )                    anion gap  resolution of acidosis
Mild DKA : Regular insulin SC or IM q 1 hr     - priming dose of RI = 0.4 – 0.6 unit/kg          • half     IV bolus          • half     SC  or  IM     - then RI 0.1 unit/kg/hr  SC  or  IM
CRITERIA  FOR  RESOLUTION  OF  DKA : ●  Glucose  <  200  mg/dl ●  Serum bicarbonate  ≥  18  mEq/l ●   Venous pH   >  7.3 When DKA resolve  If NPO :          • continue IV insulin & fluid replacement         • RI sc q 4 hr            (RI 5 unit / BS 50 mg/dl if BS > 150 mg/dl             until RI 20 unit for BS ≥ 300 mg/dl)
When DKA resolve : 2) Patient is able to eat :      - multiple-dose schedule : use combination of        short/rapid-acting + intermediate/long-acting RI      - continue IV insulin infusion for 1-2 hr after the          spit-mixed regimen      - DM : insulin dose = before the onset of DKA/HHS      - new Dx DM : 0.5-1 units/kg/day divide two doses          regimen of short + long-acting RI       - type-2 DM : oral antihyperglycemic agent & diet
POTASSIUM : • Insulin Rx, correct ȃ & volume expansion  HypoK • Prevent hypoK : replace K < 5.5 mEq/l  &                             adequate urine output • General 20-30 mEq K (2/3 KCl + 1/3 KPO4 ) in each     liter of  infusion fluid   keep serum K = 4-5 mEq/l • hypoK  (< 3.3 mEq/l) :        - K replacement  begin with fluid Rx       - insulin Rx delayed until K > 3.3 mEq/l
BICARBONATE : • controversial • keep pH > 7 for        - reestrablish insulin activity blocks lipolysis       - resolve ketoacidosis without add HCO3   • if pH < 6.9  100 mmol NaHCO3 in 400 ml sterile                           iv rate 200 ml/hr   • if pH 6.9-7.0   50 mmol NaHCO3  in 200 ml sterile                               iv rate 200 ml/hr   • if pH > 7.0   no NaHCO3        • mornitor venous pH q 2 hr until pH > 7.0    • caution : hypoK NaHCO3  in NaCl not Na > 155 mEq/l
PHOSPHATE :  Whole-body phosphate deficit in DKA = 1 mmol/kg Serum phosphate decrease with insulin Rx  I/C phosphate replacement        • cardiac dysfunction        • anemia       • respiratory depression Serum phosphate < 1 mg/dl  20-30 mEq/l K2PO4   No Rx phosphate in HHS Over phosphate Rx  hypoCa without tetany
COMPLICATIONS : ● hypoglycemia : over insulin Rx ● hypoK : insulin Rx & Rx acidosis with NaHCO3  ● hyperglycemia : interrupt/stop iv insulin after     recovery without subsequent sc insulin ● hyperchloremia : excessive saline for fluid &  E’lyte replacement
COMPLICATION : ● transient non-anion gap metabolic acidosis     (except acute renal failure or extreme oliguria) ● hypoxemia & noncardiogenic pulmonary edema    be careful in widen A-a oxygen gradient
COMPLICATION : ● Cerebral edema from osmolality :       - rapid alteration of consciousness      - headache                   - seizure         - incontinence              - bradycardia      - pupillary changes      - rapid papilledema      - respiratory arrest ☺ prevent by gradual replacement of Na & water         deficit in hyperosmolality        (max ↓ 3 mOsm/kg/hr)     ☺ In HHS : keep BS 250-300 mg/dl until  hyperosmolality & mental status improve
PREVENTION : Check up or F/U Pt education   BS goals & use short-acting RI during illness  self monitor  if BS > 300 mg/dl   be careful suppress fever & Rx infection 6)Early recovery : take easily digestible liquid diet       (carbohydrate + salt)

Contenu connexe

Tendances

Hyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic StateHyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic StateDoc Ameerul
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
ARTERIAL BLOOD GAS INTERPRETATION
ARTERIAL BLOOD GAS INTERPRETATIONARTERIAL BLOOD GAS INTERPRETATION
ARTERIAL BLOOD GAS INTERPRETATIONDJ CrissCross
 
Management of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUSManagement of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUSSurabhi Yadav
 
Ckd and anemis6295500258461766990[11826]
Ckd and anemis6295500258461766990[11826]Ckd and anemis6295500258461766990[11826]
Ckd and anemis6295500258461766990[11826]AnjaniJha10
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosisOmkar Singh
 
Insulin therapy: art of initiation and titration
Insulin therapy: art of initiation and titration Insulin therapy: art of initiation and titration
Insulin therapy: art of initiation and titration Saikumar Dunga
 
Diabetic emergencies
Diabetic emergenciesDiabetic emergencies
Diabetic emergenciesbajah423
 
Vinoedh Naidu @ nephrotic syndrome
Vinoedh Naidu @ nephrotic syndromeVinoedh Naidu @ nephrotic syndrome
Vinoedh Naidu @ nephrotic syndromeVinoedh Naidu
 
Management of hypertension problems in gp
Management of hypertension problems in gpManagement of hypertension problems in gp
Management of hypertension problems in gpAmir Mahmoud
 
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALIDDIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALIDRooma Khalid
 
A Review on Euglycemic Diabetic Ketoacidosis
A Review on Euglycemic Diabetic KetoacidosisA Review on Euglycemic Diabetic Ketoacidosis
A Review on Euglycemic Diabetic Ketoacidosisijtsrd
 
Diabetic ketoacidosis dr jayesh vaghela
Diabetic ketoacidosis dr jayesh vaghelaDiabetic ketoacidosis dr jayesh vaghela
Diabetic ketoacidosis dr jayesh vaghelajpv2212
 

Tendances (20)

Anemia wi
Anemia wiAnemia wi
Anemia wi
 
Hyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic StateHyperosmolar Hyperglycaemic State
Hyperosmolar Hyperglycaemic State
 
Dyslipdemia Guidelines Head to Head
Dyslipdemia Guidelines Head to HeadDyslipdemia Guidelines Head to Head
Dyslipdemia Guidelines Head to Head
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
ARTERIAL BLOOD GAS INTERPRETATION
ARTERIAL BLOOD GAS INTERPRETATIONARTERIAL BLOOD GAS INTERPRETATION
ARTERIAL BLOOD GAS INTERPRETATION
 
Management of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUSManagement of TYPE 1 DIABETES MELLITUS
Management of TYPE 1 DIABETES MELLITUS
 
Ckd and anemis6295500258461766990[11826]
Ckd and anemis6295500258461766990[11826]Ckd and anemis6295500258461766990[11826]
Ckd and anemis6295500258461766990[11826]
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosis
 
Managing Diabetes With Insulin by Dr Shahjada Selim
Managing DiabetesWith Insulin by Dr Shahjada SelimManaging DiabetesWith Insulin by Dr Shahjada Selim
Managing Diabetes With Insulin by Dr Shahjada Selim
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
Premixed insulin dosing in actual practice
Premixed insulin dosing in actual practicePremixed insulin dosing in actual practice
Premixed insulin dosing in actual practice
 
Hypertensive emergency
Hypertensive emergencyHypertensive emergency
Hypertensive emergency
 
Insulin therapy: art of initiation and titration
Insulin therapy: art of initiation and titration Insulin therapy: art of initiation and titration
Insulin therapy: art of initiation and titration
 
Diabetic emergencies
Diabetic emergenciesDiabetic emergencies
Diabetic emergencies
 
Vinoedh Naidu @ nephrotic syndrome
Vinoedh Naidu @ nephrotic syndromeVinoedh Naidu @ nephrotic syndrome
Vinoedh Naidu @ nephrotic syndrome
 
Management of hypertension problems in gp
Management of hypertension problems in gpManagement of hypertension problems in gp
Management of hypertension problems in gp
 
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALIDDIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
 
A Review on Euglycemic Diabetic Ketoacidosis
A Review on Euglycemic Diabetic KetoacidosisA Review on Euglycemic Diabetic Ketoacidosis
A Review on Euglycemic Diabetic Ketoacidosis
 
Insulin regimens
Insulin regimensInsulin regimens
Insulin regimens
 
Diabetic ketoacidosis dr jayesh vaghela
Diabetic ketoacidosis dr jayesh vaghelaDiabetic ketoacidosis dr jayesh vaghela
Diabetic ketoacidosis dr jayesh vaghela
 

En vedette

Dka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentDka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentEyad Miskawi
 
Diabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKADiabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKAStephen ram
 
Dka Vs Hhs Suraya
Dka Vs Hhs  SurayaDka Vs Hhs  Suraya
Dka Vs Hhs SurayaHome~^^
 
Hyperglycaemic emergencies in Diabetes mellitus
Hyperglycaemic emergencies in Diabetes mellitusHyperglycaemic emergencies in Diabetes mellitus
Hyperglycaemic emergencies in Diabetes mellitusKapil Dhingra
 
Dka pathphysiology & management 2014 - copy
Dka pathphysiology & management 2014 - copyDka pathphysiology & management 2014 - copy
Dka pathphysiology & management 2014 - copyMEEQAT HOSPITAL
 
Diabetic Ketoacidosis management update
Diabetic Ketoacidosis management updateDiabetic Ketoacidosis management update
Diabetic Ketoacidosis management updateSCGH ED CME
 

En vedette (10)

Dka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managmentDka diabetic ketoacidosis managment
Dka diabetic ketoacidosis managment
 
Diabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKADiabetes mellitus (dm) and DKA
Diabetes mellitus (dm) and DKA
 
ESRD and DKA
ESRD and DKAESRD and DKA
ESRD and DKA
 
Dka Vs Hhs Suraya
Dka Vs Hhs  SurayaDka Vs Hhs  Suraya
Dka Vs Hhs Suraya
 
DKA pathophysiology
DKA pathophysiologyDKA pathophysiology
DKA pathophysiology
 
Hyperglycaemic emergencies in Diabetes mellitus
Hyperglycaemic emergencies in Diabetes mellitusHyperglycaemic emergencies in Diabetes mellitus
Hyperglycaemic emergencies in Diabetes mellitus
 
DKA FINAL
DKA FINALDKA FINAL
DKA FINAL
 
Hyperglycemic emergency
Hyperglycemic emergencyHyperglycemic emergency
Hyperglycemic emergency
 
Dka pathphysiology & management 2014 - copy
Dka pathphysiology & management 2014 - copyDka pathphysiology & management 2014 - copy
Dka pathphysiology & management 2014 - copy
 
Diabetic Ketoacidosis management update
Diabetic Ketoacidosis management updateDiabetic Ketoacidosis management update
Diabetic Ketoacidosis management update
 

Similaire à Dka presentation1

DKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptxDKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptxradhashelly
 
DKA clinical presentation of diabetic keto acidosis
DKA clinical presentation of diabetic keto acidosisDKA clinical presentation of diabetic keto acidosis
DKA clinical presentation of diabetic keto acidosisnanikhelma
 
Management of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dkaManagement of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dkasahar Hamdy
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDr.Mansoor Elahi
 
Dibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenDibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenCSN Vittal
 
Diabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptxDiabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptxRana Shankor Roy
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic KetoacidosisSof2050
 
MANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptxMANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptxAnkit Kumar
 
ACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencyACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencytaem
 
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptxDKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptxAhmedMandour37
 
dkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptxdkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptxAhmedMandour37
 
dkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdfdkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdfHarisAliKhan22
 
Metabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusMetabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusNikhil Chougule
 
Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Acute hyperglycemic states (DKA, HHC) - Dr. KasyapaAcute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Acute hyperglycemic states (DKA, HHC) - Dr. KasyapaVeerabhadra Kasyapa J
 

Similaire à Dka presentation1 (20)

DKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptxDKA Discussion Paediatrics.pptx
DKA Discussion Paediatrics.pptx
 
DKA.pptx
DKA.pptxDKA.pptx
DKA.pptx
 
DKA .pdf
DKA .pdfDKA .pdf
DKA .pdf
 
DKA clinical presentation of diabetic keto acidosis
DKA clinical presentation of diabetic keto acidosisDKA clinical presentation of diabetic keto acidosis
DKA clinical presentation of diabetic keto acidosis
 
Management of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dkaManagement of diabetic ketoacidosis dka
Management of diabetic ketoacidosis dka
 
Diabetic ketoacidosis in children
Diabetic ketoacidosis in childrenDiabetic ketoacidosis in children
Diabetic ketoacidosis in children
 
Dibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenDibetic Ketoacidosis in Children
Dibetic Ketoacidosis in Children
 
Diabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptxDiabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptx
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
DKA.pptx
DKA.pptxDKA.pptx
DKA.pptx
 
MANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptxMANAGEMENT OF dka.pptx
MANAGEMENT OF dka.pptx
 
ACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergencyACTEP2014: What's new in endocrine emergency
ACTEP2014: What's new in endocrine emergency
 
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptxDKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx
 
dkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptxdkadrsyed2584-190602083813 (1).pptx
dkadrsyed2584-190602083813 (1).pptx
 
dkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdfdkadrsyed2584-190602083813 (1).pdf
dkadrsyed2584-190602083813 (1).pdf
 
Diabetic Ketoacidosis
Diabetic KetoacidosisDiabetic Ketoacidosis
Diabetic Ketoacidosis
 
Diabetic Crises
Diabetic CrisesDiabetic Crises
Diabetic Crises
 
DKA and HHS
DKA and HHSDKA and HHS
DKA and HHS
 
Metabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitusMetabolic emergencies in diabetes mellitus
Metabolic emergencies in diabetes mellitus
 
Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Acute hyperglycemic states (DKA, HHC) - Dr. KasyapaAcute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
 

Dernier

Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 

Dernier (20)

Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 

Dka presentation1

  • 1.
  • 2. PATHOGENESIS BOTH : insulin deficiency + elevation of counterregulatory hormones (glucagon, catecholamines, cortisol, growth hormone) ↓ Increase hepatic & renal glucose production Impaired glucose utilization in peripheral tissues ↓ Hyperglycemia & increase plasma osmolality
  • 3. PATHOGENESIS DKA : release of free fatty acids (lipolysis) ↓ Hepatic fatty acid oxidation to ketone bodies (β-hydroxybutyrate & acetoacetate) ↓ Ketonemia & metabolic acidosis
  • 4. PATHOGENESIS HHS : Plasma insulin – inadequate for glucose utilization ‒ adequate to prevent lipolysis & ketogenesis DKA & HHS : ― magnitude of dehydration ― degree of ketosis (& acidosis)
  • 5. PRECIPITATING FACTORS ● Infection ● Cerebrovascular accident ● Alcohol abuse ● Pancreatitis ● Myocardial infarction ● Trauma ● Drugs e.g. steroids, thiazides, sympathomimetic agents (dobutamine & terbutaline) ● Stop/inadequate insulin in DM type I ● Elderly with new-onset DM
  • 6.
  • 7. DIAGNOSIS History & physical examination : Process : - HHS : over several days to weeks - DKA : much shorter (typically < 24 hr) 2) Classical clinical picture of both : - polyuria - polydipsia - polyphagia - weight loss - vomitting - abdominal pain (DKA) - dehydration - weakness - clouding of sensoria - coma
  • 8. DIAGNOSIS 3) Physical finding : - poor skin tugor - Kussmaul respiration (DKA) - tachycardia - hypotension - alteration of conscious (lethargy  coma :HHS) - emesis (coffee-ground) - hypothermia (peripheral vasodilatation) - abdominal pain (DKA : Rx dehydration & metabolic acidosis)
  • 9. LABORATORY FINDINGS : 1)Initial lab : - BS, BUN, Cr, serum ketone - electrolyte (with calculated anion gap) •pseudohypoNa : osmotic gradient from hypergly. • true hypoNa from severe hyperTG • hyperK from insulin deficiency,hypotonicity& acidemia(cell shift) - osmolality : ≥ 320 mOsm/kg  stupor/coma = 2 [measured Na (mEq/L) + BS (mg/dl)/18) - CBC with diff count (leukocytosisὰ serum ketone) - U/A, urine ketone
  • 10. LABORATORY FINDINGS : 1)Initial lab: - EKG - HbA1C : acute or chronic poor control 2) Suspected infection : - bacterial cultures of urine,blood & throat ,etc - CxR - abdominal pain : pancreatitis  serum lipase (DKA : increase serum amylase & liver enz )
  • 11. DIFFERENTIAL DIAGNOSIS : Ketoacidosis: - Starvation ketosis - Alcoholic ketoacidosis mildly elevation BS (rarely > 250 mg/dl) serum HCO3 not < 18 mEQ/L 2) High-anion gap metabolic acidosis : - Lactic acidosis (Ix : serum lactate) - drugs : • salicylate (Ix : serum salicylate), • methanol (Ix : serum methanol) • ethylene glycol (Ix : U/A-calcium oxalate &hippurate crystal),
  • 12. DIFFERENTIAL DIAGNOSIS : 2) High-anion gap metabolic acidosis : - paraldehyde (strong odor breathing-osmolar gap- anion gap acidosis) - Chronic renal failure (hyperchloremic acidosis)
  • 13. TREATMENT : Correction of dehydration, hyeprglycemia & E’lyte imbalance 2) Correct precipitating factor 3) Guideline for management
  • 14. Fluid therapy : Adult patients : - initial fluid Rx in no cardiac compromise : 0.9%NaCl ≥ 15-20 ml/kg/hr in 1st hour ( ~ 1-1.5 L ) - subsequent choice for fluid depend on hydration, serum E’lyte & urine output • if N/↑serum Na  0.45% NaCl 4 – 14 ml/kg • if ↓ serum Na  0.9% NaCl - monitor BP; fluid input/output ; clinical exam ; sermoosmolality not > 3 mOsm/kg/H2O/hr - fluid replacement correct deficit in 24 hr
  • 15. FLUID THERAPY : 2) Pediatric patients (< 20 yrs) : - 1st hr : 0.9%NaCl 10-20 ml/hr ( not > 50 ml/kg in first 4 hr of therapy ) - Continued fluid therapy = fluid deficit in 48 hr or 1.5 times of 24 hr maintenance or 5 ml/kg/hr • 0.45-0.9% NaCl rate • ↓ osmolality not > 3 mOsm/kg/hr - serum glucose = 250 mg/dl  change 5%DN/2 or 5%D/N/3 with potassium
  • 16.
  • 17. INSULIN THERAPY : Not mild DKA : Rx of choice = regular insulin continuous IV infusion Exclude hypoK (< 3.3 mEq/l) Start regular insulin 0.15 units/kg iv bolus (iv bolus nit recommend in pediatric) Cont. infusion 0.1 units/kg/hr (5-7 units/hr in adult) Aim decrease BS 50-75 mg/dl/hr If in 1st hr BS not decrease > 50 mg/dl • check hydration • double dose insulin infusion every hr
  • 18. INSULIN THERAPY : when BS = 250 mg/dl in DKA or = 300 mg/dl in HHS • ↓ insulin infusion rate = 0.05 - 0.1 unit/kg/hr (3-6 units/hr) • 5-10% Dextrose Keep until acidosis in DKA mental status hyperosmolarity in HHS  resolve
  • 19. INSULIN THERAPY : Ketonemia • longer ot clear than hyperglycemia • monitor by measure serum β-OHB during Rx β-OHB  acetoacetic ȃ  worse ketosis then not use urine / serum ketone level for Rx During Rx : monitor serum E’lyte , BS, BUN, Cr, osmolality & venous pH (for DKA) q 2-4 hr ( venous pH < arterial pH = 0.03 units ) anion gap  resolution of acidosis
  • 20. Mild DKA : Regular insulin SC or IM q 1 hr - priming dose of RI = 0.4 – 0.6 unit/kg • half  IV bolus • half  SC or IM - then RI 0.1 unit/kg/hr SC or IM
  • 21.
  • 22.
  • 23.
  • 24. CRITERIA FOR RESOLUTION OF DKA : ● Glucose < 200 mg/dl ● Serum bicarbonate ≥ 18 mEq/l ● Venous pH > 7.3 When DKA resolve If NPO : • continue IV insulin & fluid replacement • RI sc q 4 hr (RI 5 unit / BS 50 mg/dl if BS > 150 mg/dl until RI 20 unit for BS ≥ 300 mg/dl)
  • 25. When DKA resolve : 2) Patient is able to eat : - multiple-dose schedule : use combination of short/rapid-acting + intermediate/long-acting RI - continue IV insulin infusion for 1-2 hr after the spit-mixed regimen - DM : insulin dose = before the onset of DKA/HHS - new Dx DM : 0.5-1 units/kg/day divide two doses regimen of short + long-acting RI - type-2 DM : oral antihyperglycemic agent & diet
  • 26. POTASSIUM : • Insulin Rx, correct ȃ & volume expansion  HypoK • Prevent hypoK : replace K < 5.5 mEq/l & adequate urine output • General 20-30 mEq K (2/3 KCl + 1/3 KPO4 ) in each liter of infusion fluid  keep serum K = 4-5 mEq/l • hypoK (< 3.3 mEq/l) : - K replacement begin with fluid Rx - insulin Rx delayed until K > 3.3 mEq/l
  • 27. BICARBONATE : • controversial • keep pH > 7 for - reestrablish insulin activity blocks lipolysis - resolve ketoacidosis without add HCO3 • if pH < 6.9  100 mmol NaHCO3 in 400 ml sterile iv rate 200 ml/hr • if pH 6.9-7.0  50 mmol NaHCO3 in 200 ml sterile iv rate 200 ml/hr • if pH > 7.0  no NaHCO3 • mornitor venous pH q 2 hr until pH > 7.0 • caution : hypoK NaHCO3 in NaCl not Na > 155 mEq/l
  • 28. PHOSPHATE : Whole-body phosphate deficit in DKA = 1 mmol/kg Serum phosphate decrease with insulin Rx I/C phosphate replacement • cardiac dysfunction • anemia • respiratory depression Serum phosphate < 1 mg/dl  20-30 mEq/l K2PO4 No Rx phosphate in HHS Over phosphate Rx  hypoCa without tetany
  • 29. COMPLICATIONS : ● hypoglycemia : over insulin Rx ● hypoK : insulin Rx & Rx acidosis with NaHCO3 ● hyperglycemia : interrupt/stop iv insulin after recovery without subsequent sc insulin ● hyperchloremia : excessive saline for fluid & E’lyte replacement
  • 30. COMPLICATION : ● transient non-anion gap metabolic acidosis (except acute renal failure or extreme oliguria) ● hypoxemia & noncardiogenic pulmonary edema be careful in widen A-a oxygen gradient
  • 31. COMPLICATION : ● Cerebral edema from osmolality : - rapid alteration of consciousness - headache - seizure - incontinence - bradycardia - pupillary changes - rapid papilledema - respiratory arrest ☺ prevent by gradual replacement of Na & water deficit in hyperosmolality (max ↓ 3 mOsm/kg/hr) ☺ In HHS : keep BS 250-300 mg/dl until hyperosmolality & mental status improve
  • 32. PREVENTION : Check up or F/U Pt education BS goals & use short-acting RI during illness self monitor  if BS > 300 mg/dl  be careful suppress fever & Rx infection 6)Early recovery : take easily digestible liquid diet (carbohydrate + salt)